A detailed analysis of the characteristics of different molecular subtypes of BC revealed that triple-negative BC exhibited a distinctive pattern of high EGFR expression, with a positivity rate as high as 80.6%, significantly higher than the Luminal subtype (58.3%) and HER2-positive subtype (67.7%). The gene discussed is ERBB2; the disease is breast cancer.